Alexandre Bazinet
机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0001-5538-4943
发表论文 241 篇 · 总被引 1375 次 · h-index 19
代表论文
- Erratum: All-Oral Combination of Revumenib, Decitabine, and Venetoclax for Relapsed or Refractory AML (SAVE) (2026 · Journal of Clinical Oncology)
- Long-term follow-up of oral decitabine/cedazuridine plus venetoclax for older or unfit patients with newly diagnosed acute myeloid leukemia (2026 · Haematologica)
- Data from Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia (2026)
- Supplementary Figure S14 from Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia (2026)
- Supplementary Figure S6 from Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia (2026)
- Supplementary Figure S10 from Incorporation of Genomic Determinants Improves Diagnostic Accuracy of Oligomonocytic Chronic Myelomonocytic Leukemia (2026)